Bottle
Latest Warner-Lambert Company Patents:
- Methods of treating neurofibromatosis type 1 with N-((R))-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide
- COMPOSITIONS OF ESSENTIALLY PURE FORM IV OF N-((R)-2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2-FLUORO-4-IODO-PHENYLAMINO)-BENZAMIDE AND USES THEREOF
- Methods of treating neurofibromatosis with N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide
- METHODS OF TREATING NEUROFIBROMATOSIS WITH N-((R)-2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2-FLUORO-4-IODOPHENYLAMINO)-BENZAMIDE
- Compositions of essentially pure form IV of N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereof
Description
FIG. 1 is a front elevational view of a bottle showing my new design, the opposite side being substantially the same in appearance;
FIG. 2 is an elevational view looking from the left of FIG. 1, the opposite side being substantially the same in appearance;
FIG. 3 is a top plan view; and
FIG. 4 is a bottom plan view.
Referenced Cited
U.S. Patent Documents
D210501 | March 1968 | Brammer |
D213307 | February 1969 | Kneapler |
D220869 | June 1971 | Kretz |
D236800 | September 1975 | Pardo |
D243657 | March 15, 1977 | Strand |
Patent History
Patent number: D247474
Type: Grant
Filed: May 20, 1976
Date of Patent: Mar 14, 1978
Assignee: Warner-Lambert Company (Morris Plains, NJ)
Inventor: David S. Byrne (Atlantic Highlands, NJ)
Primary Examiner: Robert C. Spangler
Attorney: Albert H. Graddis
Application Number: 5/688,202
Type: Grant
Filed: May 20, 1976
Date of Patent: Mar 14, 1978
Assignee: Warner-Lambert Company (Morris Plains, NJ)
Inventor: David S. Byrne (Atlantic Highlands, NJ)
Primary Examiner: Robert C. Spangler
Attorney: Albert H. Graddis
Application Number: 5/688,202
Classifications
Current U.S. Class:
D/9168
International Classification: D0901;
International Classification: D0901;